BioRestorative Therapies, Inc. (BRTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of BRTX. The 7-day demo opens the 1M and 3M ranges and puts BRTX on your watchlist.
Start 7-day demoLatest BRTX insider trades
About BioRestorative Therapies, Inc. (BRTX)
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
- MELVILLE, NY
- 14
- 1997
- Nasdaq
BRTX Form 4 activity by transaction type, last 90 days
No Form 4 activity for BRTX in the last 90 days.
BRTX insider transactions (Form 4)
53 Form 4 filings on record, the earliest from Nov 5, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Francisco Silva - Officer | Grant or award | Comon Stock | 11,719 | $32.00 | $19K | |
| Francisco Silva - Officer | Grant or award | Warrant | 11,719 | $0.00 | - | |
| Lance Alstodt - Officer | Grant or award | Common Stock | 15,625 | $32.00 | $25K | |
| Lance Alstodt - Officer | Grant or award | Warrant | 11,719 | $0.00 | - | |
| Dale Broadrick | Open-market sale | Common Stock | 1,112 | $31.60 | $2K |
BRTX insider trading FAQ
What is the latest insider trade for BRTX?
BioRestorative Therapies, Inc. (BRTX) has filed no insider reports in the last 90 days. The most recent on record is dated 20 October 2025. The full record for BRTX runs to 3 Form 4 filings, the earliest from 5 November 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BRTX stock?
No insider purchases of BRTX were filed in the last 90 days.
How many insiders are selling BRTX stock?
No insider sales of BRTX were filed in the last 90 days. 1 sale is on record for this company.
Where can I see BRTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BRTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
3The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Francisco Silva view on EDGAR
- - Lance Alstodt view on EDGAR
- - Dale Broadrick view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where BRTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BRTX with a 7-day demo
- BRTX on your watchlist
- Every BRTX Form 4 filing on record
- Up to 3 months of BRTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
